Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes.
about
A review of cardiovascular outcomes in the treatment of people with type 2 diabetes.Long-acting basal insulin analogs: latest developments and clinical usefulness.Humalog (lispro) for type 2 diabetes.The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes.
P2860
Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes.
@en
Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes.
@nl
type
label
Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes.
@en
Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes.
@nl
prefLabel
Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes.
@en
Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes.
@nl
P2860
P1476
Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes.
@en
P2093
Dario Giugliano
Katherine Esposito
P2860
P304
P356
10.1517/14712598.2012.648181
P407
P577
2012-01-04T00:00:00Z